Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Latha G

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitorsLatha G Nair, Stephane Bogen, Sumei Ruan, et al.
The American Journal of Geriatric Cardiology|March 11, 2008
Electrocardiographic intervals in the healthy geriatric population--what are the "normals"?Latha G Stead, Lekshmi Vaidyanathan, Raquel M Schears, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2008
The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology ProjectWyatt W Decker, Ronna L Campbell, Veena Manivannan, et al.
Bioorganic & Medicinal Chemistry|February 13, 2010
Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical speciesStéphane L Bogen, Ashok Arasappan, Francisco Velazquez, et al.
Neurocritical Care|April 15, 2010
Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhageLatha G Stead, Anunaya Jain, M Fernanda Bellolio, et al.
Clinical Neurology and Neurosurgery|January 1, 2010
Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?Latha G Stead, Anunaya Jain, M Fernanda Bellolio, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Sustaining improvement in door-to-balloon time over 4 years: the Mayo clinic ST-elevation myocardial infarction protocolDavid M Nestler, Amit Noheria, Luis H Haro, et al.
Journal of Medicinal Chemistry|May 22, 2009
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profilesStéphane L Bogen, Weidong Pan, Sumei Ruan, et al.
Annals of Emergency Medicine|March 15, 2008
A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillationWyatt W Decker, Peter A Smars, Lekshmi Vaidyanathan, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 InhibitorsStéphane L Bogen, Weidong Pan, Craig R Gibeau, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitorsLatha G Nair, Stephane Bogen, Sumei Ruan, et al.
The American Journal of Geriatric Cardiology|March 11, 2008
Electrocardiographic intervals in the healthy geriatric population--what are the "normals"?Latha G Stead, Lekshmi Vaidyanathan, Raquel M Schears, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2008
The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology ProjectWyatt W Decker, Ronna L Campbell, Veena Manivannan, et al.
Bioorganic & Medicinal Chemistry|February 13, 2010
Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical speciesStéphane L Bogen, Ashok Arasappan, Francisco Velazquez, et al.
Neurocritical Care|April 15, 2010
Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhageLatha G Stead, Anunaya Jain, M Fernanda Bellolio, et al.
Clinical Neurology and Neurosurgery|January 1, 2010
Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?Latha G Stead, Anunaya Jain, M Fernanda Bellolio, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Sustaining improvement in door-to-balloon time over 4 years: the Mayo clinic ST-elevation myocardial infarction protocolDavid M Nestler, Amit Noheria, Luis H Haro, et al.
Journal of Medicinal Chemistry|May 22, 2009
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profilesStéphane L Bogen, Weidong Pan, Sumei Ruan, et al.
Annals of Emergency Medicine|March 15, 2008
A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillationWyatt W Decker, Peter A Smars, Lekshmi Vaidyanathan, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 InhibitorsStéphane L Bogen, Weidong Pan, Craig R Gibeau, et al.
Pageof 9